About The Position

Are you interested in working directly for a single sponsor while having the security and additional career opportunities that working for a global CRO can bring? Our team says it’s the best of both worlds…. ClinChoice is seeking a Quality Assurance Consultant to partner with one of our sponsors for a late-phase U.S. clinical development program for a GLP-1 class therapy in obesity. This fully remote, hourly 1099 contract role will focus on proactive GCP compliance oversight, inspection readiness, and risk-based quality management across Phase IIb/III clinical trials. The ideal candidate is a seasoned clinical QA professional with hands-on audit experience and demonstrated support of FDA inspection readiness within U.S.-based late-phase trials. ClinChoice is a global full-service CRO with a strong focus on quality and professional development. As a client-facing role, we are looking for confident candidates with the ability to work independently while establishing a high-trust environment with their client counterparts.

Requirements

  • Bachelor’s degree in Life Sciences or related field.
  • Minimum 5+ years of Clinical QA experience.
  • Demonstrated experience supporting late-phase (Phase IIb/III) clinical trials in the U.S..
  • Strong working knowledge of: ICH-GCP, FDA regulatory framework, Risk-based quality management principles
  • Experience conducting GCP audits (site, process, and/or vendor).
  • Prior involvement in FDA inspection readiness activities.
  • Strong documentation and report-writing skills.
  • Ability to work independently in a fully remote environment.

Nice To Haves

  • Experience in metabolic, endocrinology, or obesity programs.
  • Exposure to GLP-1 receptor agonist development programs.
  • Experience in large, multi-site U.S. trials.
  • Experience working within sponsor oversight or FSP environments.
  • Quality certification (e.g., CQA, RAC) preferred.

Responsibilities

  • Provide independent GCP quality oversight for ongoing Phase IIb/III clinical trials.
  • Review study documentation for compliance with: ICH-GCP FDA regulations (21 CFR Parts 11, 50, 54, 56, 312) Internal SOPs and quality standards
  • Assess protocol deviations, quality trends, and study-level risk indicators.
  • Conduct remote GCP audits, including: CRO/vendor audits TMF quality reviews Process audits
  • Support FDA inspection readiness activities, including: Gap assessments Mock inspection preparation CAPA review and effectiveness checks
  • Track and trend audit findings.
  • Evaluate CRO quality systems and oversight documentation.
  • Review vendor audit reports and ensure appropriate follow-up.
  • Provide quality input into vendor governance processes.
  • Partner with Clinical Operations and functional leads to: Identify emerging quality risks Assess mitigation strategies Ensure documentation supports inspection readiness
  • Support development and refinement of quality metrics and KPIs.
  • Prepare clear, concise audit reports.
  • Develop executive summaries and quality trend reports.
  • Maintain quality documentation tracking tools.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service